5 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in CVD and CKD ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... #EBM #trial #visualabstract ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-converting enzyme inhibitor ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... CHF #Congestive #HeartFailure
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
functional ID) Treatment ... mortality and CV ... deficiency #CHF #HFrEF ... #heartfailure # ... diagnosis #management
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Ejection Fraction: Management ... hypertension, pulmonary ... #Cardiology #HFpEF ... dCHF #Diastolic #Treatment ... #HeartFailure #
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
another option in HFrEF ... milrinone) for HFrEF ... With chronic AF, HFrEF ... Revascularization, treatment ... NSAlDs, ACE-inhibitors